Zumutor Biologics, cancer therapy, biotech startup, Series B funding, immunotherapy, ZM008, NK cell therapy, oncology, biotech funding, healthcare startup, clinical trials, Accel, Bharat Innovation Fund, Premji Invest, Bengaluru biotech, India biotech sector, cancer treatment, biotechnology, startup funding, life sciences

Zumutor Biologics Raises $7.3 Million to Advance Clinical Trials of Novel Cancer Therapy

Biotechnology startup Zumutor Biologics has secured $7.3 million (approximately ₹70 crore) in a Series B funding round to advance the clinical development of its lead…

Khushi Bhatia

June 14